Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Flourishing In the Sunshine: Disclosure as a new Commercial Advantage

This article was originally published in RPM Report

Executive Summary

Orthopedic device manufacturers are out ahead of the drug industry in adapting to new payment disclosure laws. One company, Stryker, has embraced the requirement wholeheartedly and may have found a way to make the listing a benefit to doctors and patients.

You may also be interested in...

Sunshine Isn't Enough: Time for Change in Industry/Prescriber Relationships

Pharmaceutical companies understandably feel that critics of their marketing practices don’t always tell the whole story. But they cannot afford to ignore consumer attitudes about their relationships with providers. Consumers are sending a clear message: Sunshine isn’t enough; the relationships need to change.

Sens. Leahy, Kyl To Continue Push For Patent Reform In Next Congress

Encouraged by Nov. 4 election results that increased the number of Democrats in the Senate, Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., will reintroduce his controversial patent reform bill in 2009, committee staff said

Baucus health reform

Mandating disclosures of payments or gifts made by device and drug firms to health care providers, perhaps using as a model the previously introduced Physician Payments Sunshine Act, should be part of any health care reform package, states Sen. Max Baucus, D-Mont., in a Nov. 12 1white paper intended to kick off a national health reform process focusing on a public-private plan to cover all Americans. A broad-based reform package also should include the establishment of a nonprofit, private comparative effectiveness institute like that proposed in legislation sponsored by Baucus earlier this year, according to the Senate Finance Committee Chairman. Reform legislation also needs to consider hospital-physician gainsharing models that "strike the appropriate balance between thoughtful incentives for coordination of care and careful protections against financial conflicts-of-interest that could harm quality of care.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts